Search
urinary retention
Etiology: (causes not exclusive)
1) benign prostatic hypertrophy (BPH)
2) postrenal azotemia
3) overflow incontinence
4) fecal impaction, especially in the elderly
5) postoperative complication [9]
- may be contribution of opioid receptor agonist
6) pharmaceutical agents
a) parasympatholytics (oral, inhaled or parenteral)
- oxybutynin, fesoterodine
b) sedating antihistamines (loratadine & fexofenadine are exceptions)
c) sympathomimetics prevent bladder neck relaxation
- pseudoephedrine ...
d) many cold remedies contain parasympatholytics, sedating antihistamines or sympathomimetics
e) opioid receptor agonists [3]
f) calcium channel blockers
g) alpha-adrenergic agonists [3]
7) natural remedies (pharmaceutical herbs)
a) herbs containing sympathomimetics
- ephedra, ma huang, country mallow, heartleaf, bitter orange
Clinical manifestations:
- bladder fullness, palpable bladder
- sensation of incomplete bladder emptying
- urinary frequency
- urinary hesitancy
Laboratory:
- basic metabolic panel
- serum creatinine [5]
- serum potassium: hyperkalemia may occur due to RTA-4 [3]
- prostate-specific antigen in serum (men)
Special laboratory:
- post-void residual (PVR)
- PVR > 200 mL is clearly abnormal
- PVR > 300 mL in symptomatic patients should prompt catheterization
- PVR > 500 mL in asymptomatic patients should prompt catheterization [13]
- bladder scanning preferable to urinary catheter
- intermittent straight catheter preferable to indwelling urinary catheter
- if intermittent straight catheterization is required more than every 4 hours, or urine output is > 500 mL every 4 hours, transition to indwelling urinary catheter [13]
- urodynamic studies can be helpful
Radiology:
- CT of pelvis for suspected mass, but not routine [5]
Complications:
- delirium (cystocerebral syndrome)
- high 1 year mortality [2]
a) 13% without comorbity (18% if NOT due to BPH)
b) 29% with comorbidity (41% if NOT due to BPH)
Management:
- stop offending medication(s) (step 1, see etiology)
- insert foley catheter as needed
- see post-void residual (PVR) for management of PVR > or < 200 mL
- if due to benign prostatic hypertrophy, start tamsulosin [5,8]
- remove catheter in 3 days [3]
- if benign prostatic hypertrophy complicated by recurrent urinary tract infections, refer to urology for surgical options
- see postrenal azotemia
- suprapubic application of warm wet gauze may stimulate voiding, but lacks from proof of efficacy in controlled trials [9]
Related
overflow incontinence
Specific
bladder outlet obstruction
General
postrenal azotemia; obstructive uropathy
sign/symptom
References
- Prescriber's Letter 11(1):1 2004
- Armitage JN et al,
Mortality in men admitted to hospital with acute urinary
retention: Database analysis.
BMJ 2007, Nov 8
PMID: 17991937
http://dx.doi.org/10.1136/bmj.39377.617269.55
- Geriatric Review Syllabus, 7th edition
Parada JT et al (eds)
American Geriatrics Society, 2010
- Geriatric Review Syllabus, 9th edition (GRS9)
Medinal-Walpole A, Pacala JT, Porter JF (eds)
American Geriatrics Society, 2016
- Geriatric Review Syllabus, 10th edition (GRS10)
Harper GM, Lyons WL, Potter JF (eds)
American Geriatrics Society, 2019
- Geriatric Review Syllabus, 11th edition (GRS11)
Harper GM, Lyons WL, Potter JF (eds)
American Geriatrics Society, 2022
- Marshall JR, Haber J, Josephson EB.
An evidence-based approach to emergency department management
of acute urinary retention.
Emerg Med Pract. 2014 Jan;16(1):1-20; quiz 21. Review.
PMID: 24804332
- NEJM Knowledge+ Question of the Week. July 17, 2018
https://knowledgeplus.nejm.org/question-of-week/1216
- Choong S, Emberton M.
Acute urinary retention.
BJU Int 2000 Feb 15; 85:186
PMID: 10671867 Free full text
- Curtis LA, Dolan TS, Cespedes RD.
Acute urinary retention and urinary incontinence.
Emerg Med Clin North Am 2001 Sep 14; 19:591.
PMID: 11554277
- Lucas MG, Stephenson TP, Nargund V.
Tamsulosin in the management of patients in acute urinary
retention from benign prostatic hyperplasia.
BJU Int 2005 Feb; 95:354.
PMID: 15679793 Free full text
- Medical Knowledge Self Assessment Program (MKSAP) 18,
American College of Physicians, Philadelphia 2018
- Bjerregaard LS, Hornum U, Troldborg C et al
Postoperative Urinary Catheterization Thresholds of 500
versus 800 ml after Fast-track Total Hip and Knee Arthroplasty:
A Randomized, Open-label, Controlled Trial.
Anesthesiology. 2016 Jun;124(6):1256-64.
PMID: 27054365
- Stephenson A, Seitz D, Bell CM et al.
Inhaled anticholinergic drug therapy and the risk of acute urinary retention
in chronic obstructive pulmonary disease: a population-based study.
Arch Intern Med. 2011;171(10):914-920
PMID: 21606096
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/227387
- Billet M, Windsor TA.
Urinary retention.
Emerg Med Clin North Am. 2019;37(4):649-660
PMID: 31563200
https://journals.sagepub.com/doi/10.5301/RU.2013.11688
- NEJM Knowledge+ Nephrology/Urology
- Chrouser K et al.
Urinary retention evaluation and catheterization algorithm for adult inpatients.
JAMA Netw Open 2024 Jul 16; 7:e2422281.
PMID: 39012634 PMCID: PMC11252892 Free PMC article.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2821168